Ausgabe 4/2016
Inhalt (24 Artikel)
Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study)
Naoki Saji, Kazumi Kimura, Yohei Tateishi, Shigeru Fujimoto, Nobuyuki Kaneko, Takao Urabe, Akira Tsujino, Yasuyuki Iguchi
Prescriber knowledge and attitudes regarding non-administration of prescribed pharmacologic venous thromboembolism prophylaxis
Kara L. Piechowski, Stacy Elder, Leigh E. Efird, Elliott R. Haut, Michael B. Streiff, Brandyn D. Lau, Peggy S. Kraus, Cynthia S. Rand, Victor O. Popoola, Deborah B. Hobson, Norma E. Farrow, Dauryne Shaffer, Kenneth M. Shermock
Heparin-induced thrombocytopenia: reducing misdiagnosis via collaboration between an inpatient anticoagulation pharmacy service and hospital reference laboratory
Allison E. Burnett, Harmony Bowles, Matthew E. Borrego, Tiffany N. Montoya, David A. Garcia, Charles Mahan
The use of anti-factor Xa monitoring in a selection of patients receiving enoxaparin at a large academic medical center
Gretchen L. Sacha, Katie M. Greenlee, Jeffrey M. Ketz
Patient satisfaction with extended-interval warfarin monitoring
Nicholas W. Carris, Andrew Y. Hwang, Steven M. Smith, James R. Taylor, Karen Sando, Jason Powell, Eric I. Rosenberg, Marc S. Zumberg, John G. Gums, Eric A. Dietrich, Katherine Vogel Anderson
A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment
Seth Woodruff, Guillaume Feugère, Paula Abreu, Joseph Heissler, Marcia T. Ruiz, Frank Jen
Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Bengt Zöller, Xinjun Li, Jan Sundquist, Kristina Sundquist
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism
Erin R. Weeda, W. Frank Peacock, Gregory J. Fermann, Philip S. Wells, Veronica Ashton, Concetta Crivera, Thomas J. Bunz, Peter Wildgoose, Jeff R. Schein, Craig I. Coleman
Expression of tissue factor and forkhead box transcription factor O-1 in a rat model for chronic thromboembolic pulmonary hypertension
Chaosheng Deng, Dawen Wu, Minxia Yang, Yunfei Chen, Caiyun Wang, Zhanghua Zhong, Ningfang Lian, Hua Chen, Shuang Wu
Use of signals and systems engineering to improve the safety of warfarin initiation
G. Hyun, J. Li, A. R. Bass, A. Mohapatra, S. C. Woller, H. Lin, C. Eby, G. A. McMillin, B. F. Gage
Erratum to: Use of signals and systems engineering to improve the safety of warfarin initiation
G. Hyun, J. Li, A. R. Bass, A. Mohapatra, S. C. Woller, H. Lin, C. Eby, G. A. McMillin, B. F. Gage
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
Yee Cheng Lau, Qinmei Xiong, Eduard Shantsila, Gregory Y. H. Lip, Andrew D. Blann
Persistent neutrophilia is a marker for an increased risk of venous thrombosis
Margarita Kushnir, Hillel W. Cohen, Henny H. Billett
High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting
Jonathan Rilinger, Melanie Meyer, Katharina Schnabel, Patrick Weik, Anne Charlet, Jennifer S. Esser, Qian Zhou, Christoph Bode, Martin Moser, Philipp Diehl, Christoph B. Olivier
Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant
Anum S. Minhas, Qingmei Jiang, Xiaokui Gu, Brian Haymart, Eva Kline-Rogers, Steve Almany, Jay Kozlowski, Gregory D. Krol, Scott Kaatz, James B. Froehlich, Geoffrey D. Barnes
Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation
Fatima Khan, Hans Huang, Yvonne H. Datta
Effects of intermittent pneumatic compression of the thigh on blood flow velocity in the femoral and popliteal veins: developing a new physical prophylaxis for deep vein thrombosis in patients with plaster-cast immobilization of the leg
Keisuke Nakanishi, Naonobu Takahira, Miki Sakamoto, Minako Yamaoka-Tojo, Masato Katagiri, Jun Kitagawa
Missing data on 3-month modified Rankin Scale may influence results of functional outcome after intravenous thrombolysis in observational studies
Stefano Forlivesi, Manuel Cappellari, Paolo Bovi
Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients
Giulia Berti de Marinis, Stefano Novello, Silvia Ferrari, Isabella Barzon, Irene Cortella, Maria Antonietta Businaro, Fabrizio Fabris, Anna Maria Lombardi
Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke Unit
Manuel Cappellari, Mariachiara Bosco, Stefano Forlivesi, Giampaolo Tomelleri, Nicola Micheletti, Monica Carletti, Paolo Bovi
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study
Stavros V. Konstantinides, Stefano Barco, Stephan Rosenkranz, Mareike Lankeit, Matthias Held, Felix Gerhardt, Leonard Bruch, Ralf Ewert, Martin Faehling, Julia Freise, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, Michael Halank, Nadine Heydenreich, Marius M. Hoeper, Hanno H. Leuchte, Eckhard Mayer, F. Joachim Meyer, Claus Neurohr, Christian Opitz, Antonio Pinto, Hans-Jürgen Seyfarth, Rolf Wachter, Bianca Zäpf, Heinrike Wilkens, Harald Binder, Philipp S. Wild
An rs13293512 polymorphism in the promoter of let-7 is associated with a reduced risk of ischemic stroke
Li Zhang, Junsu Yang, Qiang Xue, Dong Yang, Yibing Lu, Xuefeng Guang, Weihua Zhang, Ruiqiong Ba, Hongwen Zhu, Xiang Ma
Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program
Brianne M. Ritchie, Katelyn W. Sylvester, David P. Reardon, William W. Churchill, Nancy Berliner, Jean M. Connors